Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment

• Status: Unknown status
• Trial end date: 2019-05-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to evaluate the clinical and microbiological efficacy of moxifloxacin or amoxicillin plus metronidazole in one-stage scaling and root planing in treating generalized aggressive periodontitis. Forty five subjects will be randomly allocated to 3 treatment groups. Subgingival plaque samples will be analysed for cultivable bacteria. The primary outcome variable to determine the superiority of one treatment over the others would be differences between groups for means CAL changes at 6 months post-treatment. Secondary outcome variables include differences between therapies for the mean changes in the mean levels of PD and the proportion of BOP.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Facultad Nacional de Salud Publica
• Treatments: Amoxicillin; Fluoroquinolones; Metronidazole; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination

Criteria

Inclusion Criteria:

• Subjects ≤30 years of age

• minimum of six permanent teeth, with at least one site each with probing depth (PD) and clinical attachment level (CAL) ≥5 mm and a minimum of six teeth other than first molars and incisors with at least one site each with PD and CAL ≥5 mm.

Exclusion Criteria:

• diabetes

• cardiovascular diseases

• immunological disorders or any other systemic disease that could alter the course of periodontal disease.

• Pregnant or nursing women

• smoking

• allergy to amoxicillin, metronidazole, fluoroquinolones or moxifloxacin

• consumption of systemic antimicrobials or anti-inflammatory drugs in the last 6 months

• periodontal therapy during the last 6 months